TY - JOUR AU - Tonelli Marcello AU - Coresh Josef AU - Levin Adeera AU - Jardine M AU - Gansevoort Ron AU - Levey Andrew AU - Bonventre Joseph AU - Donner Jo-Ann AU - Fogo Agnes AU - Fox Caroline AU - Heerspink Hiddo AU - Kasiske Bertram AU - Köttgen Anna AU - Kretzler Matthias AU - Luyckx Valerie AU - Mehta Ravindra AU - Moe Orson AU - Obrador Gregorio AU - Pannu Neesh AU - Parikh Chirag AU - Pollock Carol AU - Stenvinkel Peter AU - Tuttle Katherine AU - Wheeler David AU - Eckardt Kai-Uwe AU - ISN Global Kidney Health Summit participants AU - Perkovic Vlado AB -

The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5-10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury-a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.

BT - Lancet C1 - https://www.ncbi.nlm.nih.gov/pubmed/28434650?dopt=Abstract DO - 10.1016/S0140-6736(17)30788-2 IS - 10105 J2 - Lancet LA - eng N2 -

The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5-10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury-a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.

PY - 2017 SP - 1888 EP - 1917 T2 - Lancet TI - Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. VL - 390 SN - 1474-547X ER -